{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:21:24Z","timestamp":1792660884414,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Matrix metalloproteinases (MMPs) are involved in the degradation of protein components of the extracellular matrix and thus play an important role in tumor invasion and metastasis. Their expression is related to the progression of gynecological cancers (e.g. endometrial, cervical or ovarian carcinoma). In this study we investigated the expression pattern of the 23 MMPs, currently known in humans, in different gynecological cancer cell lines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In total, cell lines from three endometrium carcinomas (Ishikawa, HEC-1-A, AN3 CA), three cervical carcinomas (HeLa, Caski, SiHa), three chorioncarcinomas (JEG, JAR, BeWo), two ovarian cancers (BG-1, OAW-42) and one teratocarcinoma (PA-1) were examined. The expression of MMPs was analyzed by RT-PCR, Western blot and gelatin zymography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We demonstrated that the cell lines examined can constitutively express a wide variety of MMPs on mRNA and protein level. While MMP-2, -11, -14 and -24 were widely expressed, no expression was seen for MMP-12, -16, -20, -25, -26, -27 in any of the cell lines. A broad range of 16 MMPs could be found in the PA1 cells and thus this cell line could be used as a positive control for general MMP experiments. While the three cervical cancer cell lines expressed 10-14 different MMPs, the median expression in endometrial and choriocarcinoma cells was 7 different enzymes. The two investigated ovarian cancer cell lines showed a distinctive difference in the number of expressed MMPs (2 vs. 10).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Ishikawa, Caski, OAW-42 and BeWo cell lines could be the best choice for all future experiments on MMP regulation and their role in endometrial, cervical, ovarian or choriocarcinoma development, whereas the teratocarcinoma cell line PA1 could be used as a positive control for general MMP experiments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-553","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T18:15:00Z","timestamp":1286993700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines"],"prefix":"10.1186","volume":"10","author":[{"given":"Andrea","family":"Schr\u00f6pfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Kammerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dietl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Feix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Anacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"issue":"3","key":"2352_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2 (3): 161-174. 10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2352_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase H, Visse R, Murphy G: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006, 69 (3): 562-73. 10.1016\/j.cardiores.2005.12.002.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2352_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007, 8 (3): 211-233. 10.1038\/nrm2125.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2352_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/path.1400","volume":"200","author":"I Stamenkovic","year":"2003","unstructured":"Stamenkovic I: Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 2003, 200 (4): 448-464. 10.1002\/path.1400.","journal-title":"J Pathol"},{"issue":"7","key":"2352_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1139\/y99-055","volume":"77","author":"MA Forget","year":"1999","unstructured":"Forget MA, Desrosiers RR, Beliveau R: Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol. 1999, 77 (7): 465-480. 10.1139\/cjpp-77-7-465.","journal-title":"Can J Physiol Pharmacol"},{"issue":"24","key":"2352_CR6","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1158\/1078-0432.CCR-04-0424","volume":"10","author":"S Curran","year":"2004","unstructured":"Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI: Matrix metalloproteinase\/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res. 2004, 10 (24): 8229-8234. 10.1158\/1078-0432.CCR-04-0424.","journal-title":"Clin Cancer Res"},{"key":"2352_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001, 17: 463-516. 10.1146\/annurev.cellbio.17.1.463.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2-3","key":"2352_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/A:1023039230052","volume":"22","author":"T Shiomi","year":"2003","unstructured":"Shiomi T, Okada Y: MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev. 2003, 22 (2-3): 145-52. 10.1023\/A:1023039230052.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"2352_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0090-8258(03)00077-5","volume":"89","author":"R Tunuguntla","year":"2003","unstructured":"Tunuguntla R, Ripley D, Sang QX, Chegini N: Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol. 2003, 89 (3): 453-9. 10.1016\/S0090-8258(03)00077-5.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2352_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00004347-199810000-00002","volume":"17","author":"B Davidson","year":"1998","unstructured":"Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R: Expression of metalloproteinases and their tissue inhibitors in adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 1998, 17 (4): 295-301. 10.1097\/00004347-199810000-00002.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"2352_CR11","first-page":"267","volume":"55","author":"GJ Nuovo","year":"1995","unstructured":"Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 1995, 55 (2): 267-275.","journal-title":"Cancer Res"},{"issue":"3","key":"2352_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ygyno.2007.11.018","volume":"108","author":"PH Wang","year":"2008","unstructured":"Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD: Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array. Gynecol Oncol. 2008, 108 (3): 533-542. 10.1016\/j.ygyno.2007.11.018.","journal-title":"Gynecol Oncol"},{"issue":"15","key":"2352_CR13","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1158\/0008-5472.CAN-05-0231","volume":"65","author":"Y Zhai","year":"2005","unstructured":"Zhai Y, Hotary KB, Nan B, Bosch FX, Mu\u00f1oz N, Weiss SJ, Cho KR: Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res. 2005, 65 (15): 6543-6550. 10.1158\/0008-5472.CAN-05-0231.","journal-title":"Cancer Res"},{"issue":"2","key":"2352_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mc.20273","volume":"46","author":"KQ Cai","year":"2007","unstructured":"Cai KQ, Yang WL, Capo-Chichi CD, Vanderveer L, Wu H, Godwin AK, Xu XX: Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis. Mol Carcinog. 2007, 46 (2): 130-143. 10.1002\/mc.20273.","journal-title":"Mol Carcinog"},{"issue":"6","key":"2352_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","volume":"12","author":"AA Kamat","year":"2006","unstructured":"Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN, Han L, Gershenson DM, Sood AK: The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res. 2006, 12 (6): 1707-1714. 10.1158\/1078-0432.CCR-05-2338.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2352_CR16","first-page":"673","volume":"17","author":"K Sakata","year":"2000","unstructured":"Sakata K, Shigemasa K, Nagai N, Ohama K: Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int J Oncol. 2000, 17 (4): 673-681.","journal-title":"Int J Oncol"},{"issue":"5","key":"2352_CR17","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1111\/j.1525-1438.2006.00714.x","volume":"16","author":"D Ripley","year":"2006","unstructured":"Ripley D, Tunuguntla R, Susi L, Chegini N: Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma. Int J Gynecol Cancer. 2006, 16 (5): 1794-800. 10.1111\/j.1525-1438.2006.00714.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"2352_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0945-053X(98)90019-1","volume":"16","author":"TA Giambernardi","year":"1998","unstructured":"Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, Klebe RJ: Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 1998, 16 (8): 483-496. 10.1016\/S0945-053X(98)90019-1.","journal-title":"Matrix Biol"},{"issue":"1","key":"2352_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/gyno.2001.6573","volume":"85","author":"M Iwasaki","year":"2002","unstructured":"Iwasaki M, Nishikawa A, Fujimoto T, Akutagawa N, Manase K, Endo T, Yoshida K, Maekawa R, Yoshioka T, Kudo R: Anti-invasive Effect of MMI-166 New Selective Matrix Metalloproteinase Inhibitor, in Cervical Carcinoma Cell Lines. Gynecol Oncol. 2002, 85 (1): 103-107. 10.1006\/gyno.2001.6573.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"2352_CR20","first-page":"1103","volume":"37","author":"M Nishida","year":"1985","unstructured":"Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nippon Sanka Fujinka Gakkai Zasshi. 1985, 37 (7): 1103-1111.","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"3","key":"2352_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1749-0774.2002.tb00105.x","volume":"15","author":"M Nishida","year":"2002","unstructured":"Nishida M: The Ishikawa cells from birth to the present. Hum Cell. 2002, 15 (3): 104-117. 10.1111\/j.1749-0774.2002.tb00105.x.","journal-title":"Hum Cell"},{"issue":"2","key":"2352_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1677\/ERC-06-0085","volume":"14","author":"SM Johnson","year":"2007","unstructured":"Johnson SM, Maleki-Dizaji M, Styles JA, White IN: Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen. Endocr Relat Cancer. 2007, 14 (2): 337-350. 10.1677\/ERC-06-0085.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2352_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/0002-9378(72)90861-7","volume":"114","author":"H Kuramoto","year":"1972","unstructured":"Kuramoto H, Tamura S, Notake Y: Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol. 1972, 114 (8): 1012-1019.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2352_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1749-0774.2002.tb00103.x","volume":"15","author":"H Kuramoto","year":"2002","unstructured":"Kuramoto H, Hamano M, Imai M: HEC-1 cells. Hum Cell. 2002, 15 (2): 81-95. 10.1111\/j.1749-0774.2002.tb00103.x.","journal-title":"Hum Cell"},{"issue":"3","key":"2352_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00280-007-0628-z","volume":"62","author":"MA Navo","year":"2008","unstructured":"Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM: In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008, 62 (3): 483-9. 10.1007\/s00280-007-0628-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2352_CR26","first-page":"441","volume":"33","author":"CJ Dawe","year":"1964","unstructured":"Dawe CJ, Banfield WG, Morgan WD, Slatick MS, Curth HO: Growth in continous culture, and in hamsters, of cell from a neoplasm associated with acanthosis nigricans. J Natl Cancer Inst. 1964, 33: 441-56.","journal-title":"J Natl Cancer Inst"},{"key":"2352_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","volume":"59","author":"J Fogh","year":"1977","unstructured":"Fogh J, Fogh JM, Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977, 59: 221-226.","journal-title":"J Natl Cancer Inst"},{"key":"2352_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1477-7827-3-74","volume":"3","author":"MJ Lesmeister","year":"2005","unstructured":"Lesmeister MJ, Jorgenson RL, Young SL, Misfeldt ML: 17 Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells. Reprod Biol Endocrinol. 2005, 3: 74-10.1186\/1477-7827-3-74.","journal-title":"Reprod Biol Endocrinol"},{"key":"2352_CR29","first-page":"945","volume":"38","author":"HW Jones Jr","year":"1971","unstructured":"Jones HW, McKusick VA, Harper PS, Wuu KD: George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet Gynecol. 1971, 38: 945-949.","journal-title":"Obstet Gynecol"},{"key":"2352_CR30","first-page":"361","volume":"119","author":"C Yee","year":"1985","unstructured":"Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol. 1985, 119: 361-366.","journal-title":"Am J Pathol"},{"issue":"4","key":"2352_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrc775","volume":"2","author":"JR Masters","year":"2002","unstructured":"Masters JR: HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002, 2 (4): 315-319. 10.1038\/nrc775.","journal-title":"Nat Rev Cancer"},{"key":"2352_CR32","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.867042","volume":"196","author":"RA Pattillo","year":"1977","unstructured":"Pattillo RA, et al: Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science. 1977, 196: 1456-1458. 10.1126\/science.867042.","journal-title":"Science"},{"key":"2352_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0042-6822(85)90164-3","volume":"145","author":"MM Pater","year":"1985","unstructured":"Pater MM, Pater A: Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology. 1985, 145: 313-318. 10.1016\/0042-6822(85)90164-3.","journal-title":"Virology"},{"key":"2352_CR34","first-page":"361","volume":"119","author":"C Yee","year":"1985","unstructured":"Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology. 1985, 119: 361-366.","journal-title":"American Journal of Pathology"},{"key":"2352_CR35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/jvi.61.4.962-971.1987","volume":"61","author":"CC Baker","year":"1987","unstructured":"Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol. 1987, 61: 962-971.","journal-title":"J Virol"},{"key":"2352_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1210\/jcem-32-5-683","volume":"32","author":"PO Kohler","year":"1971","unstructured":"Kohler PO, Bridson WE: Isolation of hormone-producing clonal lines of human choriocarcinoma. J Clin Endocrinol Metab. 1971, 32: 683-687. 10.1210\/jcem-32-5-683.","journal-title":"J Clin Endocrinol Metab"},{"key":"2352_CR37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/acta.0.068S137","volume":"153","author":"PO Kohler","year":"1971","unstructured":"Kohler PO, Bridson WE, Hammond JM, Weintraub B, Kirschner MA, Van Thiel DH: Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol Suppl (Copenh). 1971, 153: 137-153.","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"10","key":"2352_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1749-6632.1971.tb34942.x","volume":"172","author":"RA Patillo","year":"1971","unstructured":"Patillo RA, Gey GO, Delfs E, Huang WY, Hause L, Garancis DJ, Knoth M, Amatruda J, Bertino J, Friesen HG, Mattingly RF: The hormone-synthesizing trophoblastic cell in vitro: a model for cancer research and placental hormone synthesis. Ann N Y Acad Sci. 1971, 172 (10): 288-298. 10.1111\/j.1749-6632.1971.tb34942.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2352_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3181\/00379727-102-25149","volume":"102","author":"R Hertz","year":"1959","unstructured":"Hertz R: Choriocarcinoma of women maintained in serial passage in hamster and rat. Proc Soc Exp Biol Med. 1959, 102: 77-81.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"7","key":"2352_CR40","first-page":"1231","volume":"28","author":"RA Pattillo","year":"1968","unstructured":"Pattillo RA, Gey GO: The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 1968, 28 (7): 1231-1236.","journal-title":"Cancer Res"},{"issue":"2","key":"2352_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N","volume":"63","author":"KR Geisinger","year":"1989","unstructured":"Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, Berens ME: Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer. 1989, 63 (2): 280-288. 10.1002\/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N.","journal-title":"Cancer"},{"issue":"8","key":"2352_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11626-996-0015-9","volume":"34","author":"WS Baldwin","year":"1998","unstructured":"Baldwin WS, Curtis SW, Cauthen CA, Risinger JI, Korach KS, Barrett JC: BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro. In Vitro Cell Dev Biol Anim. 1998, 34 (8): 649-654. 10.1007\/s11626-996-0015-9.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"3","key":"2352_CR43","first-page":"513","volume":"72","author":"AP Wilson","year":"1984","unstructured":"Wilson AP: Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J Natl Cancer Inst. 1984, 72 (3): 513-521.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2352_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0165-4608(84)90065-7","volume":"12","author":"SM Hill","year":"1984","unstructured":"Hill SM, Rodgers CS, Hult\u00e9n MA, Wilson AP: Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma. Cancer Genet Cytogenet. 1984, 12 (4): 321-327. 10.1016\/0165-4608(84)90065-7.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"2352_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijc.2910250104","volume":"25","author":"J Zeuthen","year":"1980","unstructured":"Zeuthen J, N\u00f8rgaard JO, Avner P, Fellous M, Wartiovaara J, Vaheri A, Ros\u00e9n A, Giovanella BC: Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer. 1980, 25 (1): 19-32. 10.1002\/ijc.2910250104.","journal-title":"Int J Cancer"},{"key":"2352_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1471-2407-9-188","volume":"9","author":"A K\u00f6hrmann","year":"2009","unstructured":"K\u00f6hrmann A, Kammerer U, Kapp M, Dietl J, Anacker J: Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer. 2009, 9: 188-10.1186\/1471-2407-9-188.","journal-title":"BMC Cancer"},{"key":"2352_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016\/0003-2697(76)90527-3.","journal-title":"Anal Biochem"},{"key":"2352_CR48","unstructured":"Labjournal. [http:\/\/www.laborjournal.de\/rubric\/tricks\/tricks\/trick81.html]"},{"issue":"3","key":"2352_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2559.2007.02612.x","volume":"50","author":"H Monaghan","year":"2007","unstructured":"Monaghan H, MacWhinnie N, Williams AR: The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma. Histopathology. 2007, 50 (3): 348-57. 10.1111\/j.1365-2559.2007.02612.x.","journal-title":"Histopathology"},{"issue":"5-6","key":"2352_CR50","first-page":"367","volume":"20","author":"M Sillem","year":"1999","unstructured":"Sillem M, Prifti S, Koumouridis A, Runnebaum B: Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines. Eur J Gynaecol Oncol. 1999, 20 (5-6): 367-70.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"2352_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1006\/gyno.2001.6294","volume":"82","author":"DW Park","year":"2001","unstructured":"Park DW, Ryu HS, Choi DS, Park YH, Chang KH, Min CK: Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro. Gynecol Oncol. 2001, 82 (3): 442-449. 10.1006\/gyno.2001.6294.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2352_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0090-8258(03)00335-4","volume":"90","author":"R Tanaka","year":"2003","unstructured":"Tanaka R, Saito T, Ashihara K, Nishimura M, Mizumoto H, Kudo R: Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells. Gynecol Oncol. 2003, 90 (2): 297-304. 10.1016\/S0090-8258(03)00335-4.","journal-title":"Gynecol Oncol"},{"key":"2352_CR53","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1242\/jcs.01708","volume":"118","author":"V Lyer","year":"2005","unstructured":"Lyer V, Pumiglia K, DiPersio CM: a3b1 integrin regulates MMP-9-mRNA stability in immortalized kerationcytes: A novel mechanism of integrin-mediated MMP gene expression. J Cell Science. 2005, 118: 1185-1195. 10.1242\/jcs.01708.","journal-title":"J Cell Science"},{"key":"2352_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3","volume":"87","author":"M Morini","year":"2000","unstructured":"Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, Noonan DM, Natali PG, Albini A: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion and gelatinase B (MMP-9) activity. Int J Cancer. 2000, 87: 336-342. 10.1002\/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3.","journal-title":"Int J Cancer"},{"issue":"5","key":"2352_CR55","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1111\/j.1525-1438.2006.00717.x","volume":"16","author":"O Graesslin","year":"2006","unstructured":"Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Darai E: Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer. 2006, 16 (5): 1911-1917. 10.1111\/j.1525-1438.2006.00717.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"2352_CR56","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/cncr.10355","volume":"94","author":"LA Di Nezza","year":"2002","unstructured":"Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ost\u00f6r AG, Nie G, Lopata A, Salamonsen LA: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer. 2002, 94 (5): 1466-1475. 10.1002\/cncr.10355.","journal-title":"Cancer"},{"issue":"3","key":"2352_CR57","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ygyno.2004.05.024","volume":"94","author":"R Pilka","year":"2004","unstructured":"Pilka R, Norata GD, Domanski H, Andersson C, Hansson S, Eriksson P, Casslen B: Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. Gynecol Oncol. 2004, 94 (3): 661-670. 10.1016\/j.ygyno.2004.05.024.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2352_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cncr.11030","volume":"97","author":"K Isaka","year":"2003","unstructured":"Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Takayama M: Matrix Metalloproteinase-26 Is Expressed in Human Endometrium but not in Endometrial Carcinoma. Cancer. 2003, 97 (1): 79-89. 10.1002\/cncr.11030.","journal-title":"Cancer"},{"issue":"5","key":"2352_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0928-0987(03)00146-5","volume":"19","author":"I Behrens","year":"2003","unstructured":"Behrens I, Kissel T: Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?. Eur J Pharm Sci. 2003, 19 (5): 433-42. 10.1016\/S0928-0987(03)00146-5.","journal-title":"Eur J Pharm Sci"},{"issue":"13","key":"2352_CR60","doi-asserted-by":"publisher","first-page":"10134","DOI":"10.1074\/jbc.M001599200","volume":"276","author":"J Lohi","year":"2001","unstructured":"Lohi J, Wolson CL, Roby JD, Parks WC: Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem. 2001, 276 (13): 10134-10144. 10.1074\/jbc.M001599200.","journal-title":"J Biol Chem"},{"issue":"10","key":"2352_CR61","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrm1488","volume":"5","author":"F Gebauer","year":"2004","unstructured":"Gebauer F, Hentze MW: Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 2004, 5 (10): 827-35. 10.1038\/nrm1488.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2352_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/excr.1997.3929","volume":"242","author":"M Morgan","year":"1998","unstructured":"Morgan M, Kniss D, McDonnell S: Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines. Exp Cell Res. 1998, 242 (1): 18-26. 10.1006\/excr.1997.3929.","journal-title":"Exp Cell Res"},{"issue":"1","key":"2352_CR63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neures.2007.09.009","volume":"60","author":"J Stojic","year":"2008","unstructured":"Stojic J, Hagemann C, Haas S, Herbold C, K\u00fchnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH: Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 I correlated with the WHO-grading of human malignant gliomas. Neurosci Res. 2008, 60 (1): 40-49. 10.1016\/j.neures.2007.09.009.","journal-title":"Neurosci Res"},{"issue":"5","key":"2352_CR64","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1139\/o06-084","volume":"84","author":"LB da Silva Cardeal","year":"2006","unstructured":"da Silva Cardeal LB, Brohem CA, Corr\u00eaa TC, Winnischofer SM, Nakano F, Boccardo E, Villa LL, Sogayar , Maria-Engler SS: Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol. 2006, 84 (5): 713-719. 10.1139\/O06-084.","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"2352_CR65","first-page":"565","volume":"9","author":"Y Kato","year":"2002","unstructured":"Kato Y, Yamashita T, Ishikawa M: Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep. 2002, 9 (3): 565-569.","journal-title":"Oncol Rep"},{"issue":"8","key":"2352_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00432-006-0096-6","volume":"132","author":"A Mitra","year":"2006","unstructured":"Mitra A, Chakrabarti J, Banerji A, Das S, Chatterjee A: Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol. 2006, 132 (8): 505-513. 10.1007\/s00432-006-0096-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"2352_CR67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/molehr\/8.7.659","volume":"8","author":"J Zhang","year":"2002","unstructured":"Zhang J, Cao YL, Zhao YG, Sang QX, Duan EK: Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod. 2002, 8 (7): 659-666. 10.1093\/molehr\/8.7.659.","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"2352_CR68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.placenta.2006.04.001","volume":"28","author":"N Di Simone","year":"2007","unstructured":"Di Simone N, Di Nicuolo F, Sanguinetti M, Ferrazzani S, D'Alessio MC, Castellani R, Bompiani A, Caruso A: Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta. 2007, 28 (4): 298-304. 10.1016\/j.placenta.2006.04.001.","journal-title":"Placenta"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-553\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:15:25Z","timestamp":1630613725000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2352"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-553","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]},"assertion":[{"value":"23 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"553"}}